A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
Clinical trial NCT01813812 · UNKNOWN
Trial details
- NCT number
- NCT01813812
- Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-08-01
- Enrollment
- 492
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.